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bjectives This study evaluated the protective effect of nitric oxide–coating of introducer sheath
n the local complications in juvenile porcine femoral arteries with similar size to human radial
rteries.
ackground Insertion of an introducer sheath induces vasospasm and transient or permanent
essel occlusion of radial arteries.
ethods Nitric oxide–coated or control introducer sheaths with or without spasmolytic cocktail
control  C-sheath) were inserted into porcine femoral arteries, followed by percutaneous coronary
ntervention (PCI). The diameter of the femoral artery at the puncture site, distally and proximally,
as measured by quantitative angiography. Histopathological and histomorphometric parameters of
he femoral arteries were analyzed 1 h or 1 week after PCI.
esults Insertion of femoral sheath led to mild or severe spasms, with signiﬁcantly higher vessel
iameter at the access site (2.69  0.81 mm vs. 1.77  0.77 mm and 1.85  0.66 mm, p  0.001),
nd proximal and distal to it, during PCI in the nitric oxide–sheath group versus the control-sheath
nd control  C-sheath groups, respectively. Immediately following PCI, signiﬁcantly less luminal
hrombosis (12% vs. 33% and 31% of all analyzed segments, p  0.001) was observed in the nitric
xide–sheath arteries. At 1 week, lower intimal inﬂammation score (0.43  11 vs. 1.03  0.35 and
.04  0.32, p  0.05), less luminal thrombosis (8% vs. 21% and 30% p  0.05), and smaller intimal
yperplasia (0.31  0.31 mm2 vs. 0.47  1.00 mm2 and 0.86  0.82 mm2, p  0.05) were observed
n NO-sheath arteries at the injury site.
onclusions Nitric oxide coating on the introducer sheath prevents local complications during PCI
nd results in less vascular thrombosis and inﬂammation at the access site, contributing to patency
f the access vessel with similar size to the radial artery. (J Am Coll Cardiol Intv 2011;4:98–106)
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99nsertion of an introducer sheath in the peripheral artery for
ercutaneous coronary angiography or percutaneous coro-
ary intervention (PCI) may cause local complications at the
ccess site, such as local arterial spasms, dissection, arterial
tenosis, or occlusion, especially using the transradial ap-
roach (1–3). Most invasive cardiology centers traditionally
se the femoral access for coronary angiography and PCI,
ut the transradial approach is becoming more popular due to
conomic considerations (early mobilization of the patients),
nd less local bleeding complications (4,5). Definitive hand
schemia is negligible at the radial access site due to the deep
nd superficial palmar arches. Moreover, the radial artery
an be compressed easily and effectively to achieve a primary
emostasis, even if the patient receives aggressive anti-
hrombotic treatment (6).
On the contrary, severe local complications, such as
eriprocedural spasms of the radial artery, occur in up to 9%
nd occlusions in up to 6% of cases (7). A recent optical
oherence tomography study of the radial artery revealed
ntimal tear in 32%, medial dissection in 16%, and throm-
osis in 20.5% of cases after sheathing (8). To circumvent
hese limitations, several strategies have been developed,
uch as hydrophilic coating of the sheaths for reduction of
riction (9), short sheaths with smaller lumen diameter
2,3,10), and local or systemic administration of various
asodilators, such as calcium-channel blocker, nitrovasodi-
ators, alone or in combination, as a spasmolytic cocktail
2,11). Nevertheless, the dramatic increase in the number of
iagnostic coronary angiography and PCI with frequent
ntentions to repeat both procedures in the same patient,
nd the use of radial artery for bypass conduit necessitates
ew approaches to prevent severe local complication and
cclusion of the radial artery after coronary procedures.
Nitric oxide (NO) is a potent vasodilator with an inhib-
tory effect on platelet aggregation and proliferation of
ascular smooth muscle cells, reducing thrombus and neo-
ntimal formation (12). Theoretically, coating of radial
ntroducer sheaths with NO might beneficially influence
asospasm, and the consequent local vascular complications.
Accordingly, the aim of our study was to investigate the
ffect of an NO-coated introducer sheath on mechanically
nduced, PCI-related local peripheral vasospasm and occlu-
ion of the artery, as well as on the histological changes of
he femoral arteries of juvenile pigs, with similar vessel size
o human radial or cubital arteries.
ethods
O-eluting sheath. The NO-eluting sheath (Millimed A/S,
oskilde, Denmark) was produced by Thomas Medical Prod-
cts, Inc. (Malvern, Pennsylvania) and then coated, packed,
nd electron-beam sterilized. The NO-eluting coating was
onstructed as a “base coat” containing a combination of a
O-loaded linear polyethyleneimine, polyurethanes, and a colymeric matrix, and a “top coat” with only a polymeric
atrix. The NO-loaded linear polyethyleneimine releases NO
hen it is exposed to a proton-donating (H) environment
uch as blood. Incorporating the NO-loaded linear polyethyl-
neimine into a polymer matrix along with top coating allows
he controlled release of NO over 2 h. The NO-coated sheath
ad a release rate of 0.5 to 7.0 nmol/l NO/min/cm2, which is
onsidered within the therapeutic window, without toxic ef-
ects. Nitric oxide is delivered into the surrounding tissues of
he vessel wall by dispersed diffusion from the sheath. The
iffusion of NO from catheters coated using the same tech-
ology was tested in isolated rat aorta and human vessels,
emonstrating the inhibition of norepinephrine-induced vaso-
onstriction (13).
nimal preparation. Twenty-eight domestic pigs (weight 12
o 15 kg) were fasted overnight and then sedated with 12
g/kg ketamine hydrochloride and 1 mg/kg xylazine and 0.04
g/kg atropine. After pre-medication, the anesthesia was
eepened with isoflurane and O2 via a mask. After intratra-
heal intubation, the anesthesia was maintained with 1.5 to 2.5
ol% isoflurane, 1.6 to 1.8 vol% O2, and 0.5 vol% N2O.
One day before the procedure, a loading dose of 250 mg
spirin and 300 mg clopidogrel were administered orally.
ccess to the right or left femoral
rtery was performed through di-
ect puncture of the artery under
terile conditions, and a 6-F in-
roducer sheath, either a NO-
oated device or a noncoated
ontrol device (Radiofocus In-
roducer II, 6-F, Terumo Med-
cal Corporation, Somerset, New Jersey) was inserted into
he artery, in a randomized fashion in the arteries of 20 pigs
Fig. 1). After insertion of a control sheath, 10 ml vasodi-
ation cocktail containing of 0.1 mg nitroglycerin, 1 ml
idocaine (2%), and 2.5 mg verapamil was administered
ntra-arterially via the sheath in the next 8 pigs (control 
-arteries).
After administration of 100 IU/kg of heparin sodium,
ngiographies of the femoral and iliac arteries were per-
ormed with regular contrast media (Ultravist, Bayer, Le-
erkusen, Germany) and a 6-F–guiding catheter (Hockey
tick, Cordis Cardiology, Miami Lakes, Florida) was ad-
anced into the ascending aorta. The coronary angiography
as followed by PCI simulating the shear stress of the
emoral arteries during the mechanical manipulation of the
atheter with wires and balloons. After PCI, the guiding
atheter was removed and the angiography of the femoral
rtery was repeated, and the sheaths were removed. Ten
nimals with either NO-sheath or control sheath, and 4 pigs
rom the control  C-sheath group were euthanized, and a
ercutaneous closure of the puncture site was performed
ith an Angio-Seal (St. Jude Medical, St. Paul, Minnesota)
Abbreviations
and Acronyms
NO  nitric oxide
PCI  percutaneous
coronary interventionlosure device in the remaining 14 pigs (Fig. 1), replacing
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100he original sheath by the Angio-Seal sheath. After removal
f the guidewire, hemostasis was achieved by the mechan-
cal means of the anchor-arteriotomy-collagen sandwich of
he device, which is supplemented by the coagulation-
nducing properties of the collagen (14). These pigs were
llowed to recover and survived for 1 week after PCI, and
hen they were euthanized. The euthanasia was performed
ith 10 ml saturated potassium chloride, and the femoral
rteries were harvested for histomorphometric and histo-
Figure 1. Study Design
Flow diagram depicting the study design. Twenty femoral arteries (right and le
(NO)-coated sheath, whereas the contralateral artery received the other type o
femoral arteries and vasodilation cocktail was locally injected. a. fem.  arteriahathological assessments. collow-up examinations. During the 1-week follow-up pe-
iod, daily doses of 100 mg aspirin and 75 mg clopidogrel
ere administered orally. After 7 days, control angiography
f the femoral arteries was performed through a carotid
rtery access to figure both (left and right) femoral arteries,
nder general anesthesia. Subsequently, the animals were
uthanized. The experiments were conducted at the Insti-
ute of Diagnostics and Radiation Oncology (University of
aposvar, Kaposvar, Hungary). The animal investigations
20 pigs were randomized to receive either control sheath or nitric oxide
heath. Additionally, 8 pigs received control sheaths in both (right and left)
ralis; PCI  percutaneous coronary intervention.ft) of
f the s
femoonform to the “Position of the American Heart Associa-
t
H
f
A
Q
d
e
t
c
a
d
d
m
t
H
a
a
w
a
T
c
s
s
1
r
2
s
o
o
q
r
s
t
f
i
o
g
i
m
o
a
m
F
m
1
r
a
t
t
p
n
a
a
a
1
S
g
p
i
g
S
a
a
S

J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 1 , 2 0 1 1 Hemetsberger et al.
J A N U A R Y 2 0 1 1 : 9 8 – 1 0 6 NO-Coated Introducer Prevents Complications
101ion on Research Animal Use,” adopted by the American
eart Association on November 11, 1984. All animal
acilities met the standards of the American Association for
ccreditation of Laboratory Animal Care.
uantitative assessment of femoral angiography. Periproce-
ural and follow-up angiographic parameters of the periph-
ral arteries were evaluated using a computer-assisted quan-
itative angiographic edge detection algorithm (quantitative
oronary angiography, ACOMPC, Siemens, Germany), by
n independent observer blinded to the experimental con-
itions. The vessel diameter at the access site and the
iameters proximal and distal to the puncture site were
easured, immediately after sheath placement, at the end of
he PCI (at 1 h), and after 1 week in the surviving animals.
istopathology and histomorphometry of the femoral
rteries. The harvested femoral arteries were flushed with
pproximately 100 ml saline and then pressure fixed in situ
ith 4% buffered formaldehyde for 20 min. Afterward, the
rteries were fixed in formalin and embedded in paraffin.
he segments of the Angio-Seal sites (proximal and distal 1
m) were not included in the analyses. The following
egments of the femoral arteries have been sectioned: serial
ections of the artery proximal to the access site cut into
0 segments (1 cm of each), and proximal and distal
eference segments within 2 cm proximal to sheath end and
cm distal to the puncture site. Sections of each arterial
egment were stained with hematoxylin-eosin. All segments
f the arteries were evaluated separately by an experienced
bserver blinded to the groups, and the mean values of the
uantitative histopathological and histomorphometric pa-
ameters of 1 artery were entered into the statistical analysis.
The quantitative histopathological (15) analysis included the
cores of intimal and adventitial inflammation, fibrin deposi-
ion, and presence of thrombus. Intimal inflammation was scored
Table 1. Quantitative Angiographic Results of the Femoral Arteries After N
(Control Sheath and Control  C-Sheath With Vasodilation Cocktail)
Time Sheath Group
Vess
Pu
After sheath placement NO-sheath (n 20 arteries)
Control sheath (n 20 arteries)
Control  C-sheath (n 16 arteries)
p values
After coronary intervention NO-sheath (n 20 arteries)
Control sheath (n 20 arteries)
Control  C-sheath (n 16 arteries)
p values
At 1-week follow-up NO-sheath (n 10 arteries)
Control sheath (n 10 arteries)
Control  C-sheath (n 8 arteries)
p values
The vessel diameter distal to the sheath placement is larger than that of the puncture site, due to sp(NO)-sheath versus control sheath and control C-sheath by t test. *p 0.005 between nitric oxide (NO)-rom 0 to 3 as absent, mild, moderate, or heavy inflammation,
nvolving 10%, 10% to 25%, or 25% of the circumference
f the intima, respectively. Adventitial inflammation score was
raded as 0 for no inflammation; 1 for mild inflammatory
nfiltration or focally moderated in 25% of the vessel area in
edia or adventitia; 2 for moderate inflammatory infiltration
r focally marked in 25% to 50% of the vessel area in media or
dventitia; 3 for heavy inflammatory infiltration or focally
arked in 50% of the vessel area in media or adventitia.
ibrin score was graded from 0 to 3 as no fibrin deposition or
ild, moderate, or heavy fibrin deposition, involving 10%,
0% to 25%, or 25% of the circumference of the vessel,
espectively. Necrosis and hemorrhage were scored from 0 to 3
s no change, mild, moderate, or heavy changes in any layer of
he vessel, involving 0%, 1% to 10%, 10% to 25%, or25% of
he circumference of the vessel, respectively. Furthermore, the
resence of mural thrombus was identified.
The histomorphometric analysis included the lumen, inter-
al elastic lamina, media, external elastic lamina, adventitial
reas, and percent area stenosis. The area between the lumen
nd internal elastic lamina was defined as the area of platelet
nd leukocyte attachment to the intima and mural thrombus at
-h follow-up and as neointimal area at 1-week follow-up.
tatistics. Continuous parameters of the arteries of different
roups (all of them showing normal distribution) were ex-
ressed as mean  SD. Categorical variables were character-
zed as percentages. The continuous variables of the sheath-
roups were compared by analysis of variance supplemented by
tudent t test. Differences in categorical variables were evalu-
ted by chi-square test and Fischer exact test. Statistical
nalyses were carried out using SPSS software (version 17.0,
PSS, IBM Corporation, Somers, New York). A p value of
0.05 was considered statistically significant.
ing (NO-Sheath) and Control Sheath Placement
meter at the
Site (mm)
Vessel Diameter Proximal
to Puncture Site (mm)
Vessel Diameter Distal to
Puncture Site (mm)
1.13 4.28 0.55 3.03 0.42
0.64 4.04 0.52 2.62 0.62
0.71 4.11 0.51 2.65 0.59
S NS NS
0.81 4.27 0.40 3.37 0.46
0.77* 3.77 0.42* 2.74 0.53*
0.66* 3.75 0.45* 2.62 0.44*
.001 0.001 0.001
0.92 4.74 0.80 4.02 0.69
0.99 4.12 0.66 3.80 1.10
0.85 4.15 0.54 3.81 0.71
S NS NS
he artery. The p values represent the results of analysis of variance. *p 0.005 between nitric oxideO-Elut
el Dia
ncture
2.30
2.03
2.09
N
2.69
1.77
1.85
0
4.24
4.02
4.10
N
asm of tsheath versus control sheath and control C-sheath by t test.
RQ
t
d
a
m
a
a
s
a
a
w
P
w
a
d
H
a
v
i
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 1 , 2 0 1 1
J A N U A R Y 2 0 1 1 : 9 8 – 1 0 6
Hemetsberger et al.
NO-Coated Introducer Prevents Complications
102esults
uantitative coronary angiography. The animals with con-
rol  C-sheath exhibited an insignificant systolic pressure
rop immediately after intra-arterial administration of the
ntispasmodic cocktail (from 112  13 mm Hg to 101  14
m Hg), which was not observed in the other animals.
Visually, most of the arteries were in spasm immediately
fter sheath placement as confirmed by quantitative coronary
ngiography, and the access site lumen diameter was even
maller than the diameter of the distal part of the arteries with
Figure 2. Representative Angiograms of the Femoral Arteries After Sheath
Arteria femoralis angiograms before (A), immediately after (B), and 1 h (C) afte
coated sheaths, and 1 week after the coronary procedure (D). Note that the ar
eluting sheath, after sheath placement and at 1-h follow-up (arrows). Comple
(middle B), with only partial recovery post-PCI (middle C), and no abnormality at foll types of sheaths (Table 1, Fig. 2). A slightly larger vessel size
t the proximal site was measured in the control  C-arteries,
ith no statistical difference between the groups. At the end of
CI, significantly larger vessel diameter of the femoral arteries
ith the NO-sheath was measured at the access site, as well as
t the proximal and distal sites. At 1-week follow-up, no
ifferences between the groups were noted (Table 1).
istopathology of the femoral arteries. Histopathological
nalysis revealed the adhesion of leukocytes and platelets to the
essel wall endothelium at the access sites with signs of acute
ntimal and adventitial inflammation and hemorrhage 1 h after
ment
ement of control or control with vasodilation cocktail and nitric oxide–
with the control sheaths are more spastic than the arteries with nitric oxide–
lusion of the femoralis artery after sheath placement (control sheath  C)Place
r plac
teries
te occllow-up (middle D). Abbreviations as in Figure 1.
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103CI, without significant difference between the groups. How-
ver, small thrombus formation was observed significantly
ore often in the control sheath groups (Table 2).
After 1 week, significantly less intimal inflammation and
resence of mural thrombi were found in the NO-sheath
rteries compared with the control arteries (Fig. 3, Table 2).
istomorphometry of the femoral arteries. The arteries of
he NO-sheath group showed significantly smaller intimal
rea (consisting of mural thrombi, adhesive platelets, and
eukocytes) and percent area stenosis at 1 h (Table 3), and
maller neointimal hyperplasia at the injury site at the
-week follow-up (Table 4).
iscussion
o our knowledge, this is the first study presenting the
pasmolytic, anti-inflammatory, and antithrombotic effect
f the NO-eluting introducer sheath on the peripheral
rteries. Nitric oxide released from the sheath diminished
he vasoconstrictive response of the access artery, ensuring
igher intraluminal diameter during the coronary proce-
ure, which in turn makes the local peripheral manipulation
afer. In addition, the local NO release inhibited thrombus
ormation and inflammatory reaction at the access site,
ontributing to the patency of the peripheral access artery
ollowing PCI at the vessel size of the human radial artery.
eneﬁts and disadvantages of distinct access sites. The
ajor limitations of the radial access are the entry site failure
ith the necessity of crossover to an alternative access route,
he higher radiation dose, the longer procedural time, and
he occlusion or spasm of the radial artery. These drawbacks
ay offset the benefits of this access mode, hindering the
witch from femoral to radial approach in most catheteriza-
ion laboratories (16). Even if definitive complications, such
s asymptomatic or symptomatic vessel closure, or develop-
ent of significant neointima are rare, as radial access
ccounts for 10% of the procedures worldwide, and 1%
n the U.S. (16), the absolute number is rapidly growing.
herefore, the prevention of the definitive vessel injury is
Table 2. Histopathological Results of the Femoral Arteries After NO-Eluting
(Control Sheath and Control  C-Sheath With Vasodilation Cocktail), After
Time Sheath Group
Inflamma
Intima
After coronary intervention NO-sheath (n 10 arteries) 0.65
Control sheath (n 10 arteries) 0.87
Control  C-sheath (n 8 arteries) 0.85
p value N
At 1-week follow-up NO-sheath (n 10 arteries) 0.43
Control sheath (n 10 arteries) 1.03
Control  C-sheath (n 8 arteries) 1.04
p value 0
Thepvalues represent the results of analysis of varianceor chi-quadrate test, respectively. *p0.05bAbbreviations as in Table 1.mportant, especially in patients with expected repeat an-
iography or PCI or candidate for coronary bypass surgery
ith planned radial artery as conduit.
hear stress of the access artery during coronary angiography
nd intervention. In daily practice, radial arterial spasm is
anifested by the resistance against advancing the intra-
rterial equipment and by the patient’s complaint of forearm
ain (17). Principally, the spasm is necessary for natural
emostasis; however, it might be harmful when a sheath lies
n the artery. The radial artery has multiple tight muscle
ayers in the media, with higher density of smooth muscle
ells compared with the femoral artery. The predominance
f alpha-adrenoceptors in the radial artery leads to rapid
asoconstriction to shear stress-induced local release of
atecholamines, serotonin, endothelin I, and angiotensin II
18). The subsequent spasm induces friction of the arterial
all in contact with the sheath, further increasing shear
tress and leading to intimal tear or medial dissection not
nly at the access site, but also at the proximal and distal
ortion of the artery with subsequent thrombosis (8).
ccordingly, the observed changes of porcine femoral ar-
eries might even underestimate the histopathological alter-
tions of a radial artery during catheterization. This is
upported with the recently published optical coherence
omography study of human radial arteries (8).
Usually, the radial artery spasms can be sufficiently
anaged with intra-arterial spasmolytic cocktails (17). Im-
ediate angiography post-sheathing revealed that most of
he arteries are affected promptly after sheath placement, as
he access site lumen diameter was even smaller than the
iameter of the distal part of the artery, even after intra-
rterial administration of the vasodilation cocktail.
O-coated introducer sheath in the prevention of vascular
nﬂammation and thrombosis. Acute vascular damage is
nown to induce a very early immune response with inflam-
atory cell invasion, increased extracellular matrix turnover,
nd oxidative stress (19). The introducer sheath causes a
Sheath) and Control Sheath Placement
nary Intervention and at 1-Week Follow-Up
the
)
Inflammation in the
Adventitia (Score)
Necrosis
(Score)
Hemorrhage
(Score)
Thrombosis
(%)
0.05 0.12 0 0.31 0.38 12%
0.06 0.15 0 0.21 0.37 33%*
0.06 0.09 0 0.30 0.28 31%*
NS NS NS 0.001
0.15 0.15 0 0.14 0.17 8%
0.27 0.34 0 0.33 0.65 21%*
0.32 0.11* 0 0.27 0.22 26%*
NS NS NS 0.005
NO-sheath versus control sheath and controlC-sheathby t test, or Fischer exact test, respectively.(NO-
Coro
tion in
(Score
0.32
0.47
0.44
S
0.11
0.35*
0.32*
.05
etween
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104echanical vascular trauma, triggering pathological changes in
he vessel (8).
In contrast, elution of NO from the coated sheath during
CI reduced the vasoconstriction and decreased the inflam-
atory and thrombotic reactions. More than 20% of the
essels showed mural thrombus, even a week after the
oronary procedure, with increased intimal inflammation
nd neointimal hyperplasia. Although NO has a short
alf-life, the permanent contact with the vessel wall at the
ccess site with continuous and stable elution from the
O-coated sheath seems to be sufficient to relieve vessel
onstriction and to inhibit platelet and leukocyte deposition,
hich might contribute to vascular healing and patency of
he affected artery. Even, if the observed histological differ-
Figure 3. Representative Histological Images of the Femoral Arteries After
Additional Vasodilation Cocktail
Control sheaths (A to D): platelet and leukocyte adhesion on the intima (arro
moderate intimal hyperplasia (arrow) (C), light intimal hyperplasia (dotted arr
oxide–coated sheath (E): no intimal hyperplasia, no platelet or leukocyte adhences between the sheaths seem not to be relevant clinically ft the first look, the histopathological changes and their
requency found in our animals are similar to that of the
uman radial arteries (8), shedding light to the high
requency of mostly unrevealed local complications.
Although our results may also be applied to the femoral
rteries, the size of the access site of the juvenile porcine
rtery is similar to that of the human radial arteries (2.5 to
.1 mm). Moreover, the femoral artery is less prone to
pasm, and because of larger size in humans, the compro-
ise of the vessel lumen resulting from intimal hyperplasia
r small mural thrombus does not lead to ischemic limb
omplication.
tudy limitations. In contrast with the potentially compro-
ised human radial arteries with limited vasomotion, the
ment of Nitric Oxide–Coated Sheath and Control Sheath With or Without
after control sheath placement (A), an organized thrombosis (arrow) (B),
nd inﬂammation (arrow) in the adventitia at 1-week follow-up (D). Nitric
n the intima (dotted arrow), and no inﬂammation in the adventitia (arrow).Place
w) 1 h
ow) aemoral arteries of the juvenile pigs are healthy. However,
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105ntravascular ultrasound obtained from radial arteries of
atients undergoing transradial catheterization revealed sig-
ificant plaque only in 8.6%, calcium deposition in 8.6%,
nd diffuse atherosclerosis in 6.9% of cases (20). The radial
rtery of pigs is too short, and because of the curvature of
he brachialis and subclavian artery, a catheterization
ethod similar to humans is impossible. Despite the dif-
erences between the human radial arteries and porcine (and
uman) femoral arteries, to our knowledge, there is no other
elevant animal model for radial artery approach.
We have used saturated potassium chloride for euthanasia,
hich might cause acute vasoconstriction, influencing the
istomorphometric results. However, saturated potassium
hloride causes cardiac arrest within a few seconds and is a
ecommended agent for primary euthanasia (American Asso-
iation for Accreditation of Laboratory Animal Care) in pigs.
The aspirin and clopidogrel doses were not adjusted for
orcine weight. However, the doses of both medicines are
tandard for patient care with PCI, without weight adjust-
ent, and for pre-clinical experiment involving coronary
tenting in pigs.
In the surviving animals, we have closed the femoral
uncture site with the Angio-Seal, which cannot be used in
human radial artery. However, the femoral arteries of pigs
Table 3. Histomorphometric Results of the Femoral Arteries Immediately A
(Control Sheath and Control  C-Sheath With Vasodilation Cocktail), After
Sheath Groups
(Post-PCI)
Lumen Area
(mm2)
Intimal Area
(mm2)
IEL A
(mm
NO-sheath (n 10 arteries) 3.18 1.45 0.24 0.27 3.42
Control sheath
(n 10 arteries)
3.18 1.66 0.33* 0.35 3.51
Control  C-sheath
(n 8 arteries)
3.21 1.46 0.36* 0.29 3.49
p value NS 0.05 N
Intimal area consisted of adhesive leukocytes and platelets and initial mural thrombosis. The p valu
control C-sheath by t test.
%AS percent area stenosis; EEL external elastic lamina; IEL internal elastic lamina; other ab
Table 4. Histomorphometric Results of the Femoral Arteries 1 Week After
Control Sheath Placement (Control Sheath and Control  C-Sheath With V
Sheath Groups
(at 1-Week Follow-Up)
Lumen Area
(mm2)
Intimal Area
(mm2)
IEL Are
(mm2
NO-sheath
(n 10 arteries)
3.32 1.32 0.31 0.31 3.63 1.
Control sheath
(n 10 arteries)
2.92* 1.39 0.47* 1.00 3.39 1.
Control  C-sheath
(n 8 arteries)
2.73* 0.77 0.86* 0.82 3.57 0.
p value 0.05 0.05 NS
The p values represent the results of analysis of variance. *p 0.005 between NO-sheath versus coAbbreviations as in Tables 1 and 3.annot be compressed safely without the fear of bleeding
omplication after recovery of the animals from anesthesia.
o prevent the ligation of the femoral artery (which is the
tandard method after coronary catheterization of pigs) with
ubsequent thrombosis distal and proximal to access site and
o ensure the patency of the femoral artery, we set the
losure device, as a compromised solution, and performed
he control angiography from carotid access. Nevertheless,
he local places of the anchor and collagen were not entered
nto the histological analyses.
Severe spasm of the artery at the access site occurs usually at
he time of puncture or multiple failed punctures, or due to
atheter manipulation in a tortuous radial and subclavian
rtery. However, we intended to call attention to the local
omplications of the access site during and after catheteriza-
ion, if puncture and catheterization were seemingly successful.
onclusions
O-eluting introducer sheaths prevent the acute, mechan-
cally induced vasoconstriction of the access artery during
ardiac catheterization and result in less thrombosis and
ocal inflammation, contributing to vessel patency.
CI After NO-Eluting (NO-Sheath) and Control Sheath Placement
Media Area
(mm2)
EEL Area
(mm2)
Adventitia Area
(mm2)
%AS
(%)
1.99 0.71 5.41 1.76 7.31 2.41 6.8 5.2
1.90 0.69 5.41 1.92 7.01 2.51 8.9* 6.3
2.02 0.71 5.50 2.04 7.29 2.58 9.6* 6.9
NS NS NS 0.05
esent the results of analysis of variance. *p 0.005 between NO-sheath versus control sheath and
ions as in Table 1.
ary Intervention After NO-Eluting (NO-Sheath) and
lation Cocktail)
Media Area
(mm2)
EEL Area
(mm2)
Adventitia Area
(mm2)
%AS
(%)
1.98 0.96 5.61 1.94 7.31 2.61 7.9 5.6
2.01 0.89 5.41 1.53 7.16 1.99 13.2* 15.7
2.23 0.74 5.79 1.25 7.44 1.86 24.1* 13.7
NS NS NS 0.01
eath and control C-sheath by t test.fter P
PCI
rea
2)
1.62
1.86
1.33
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